The University of Arkansas is a public land-grant research university in Fayetteville, Arkansas. It is the flagship campus of the University of Arkansas System and the largest university in Arkansas.

During the past decade, University of Arkansas conducted 26 clinical trials. In the 10-year time frame, 26 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University of Arkansas" #1 sponsor was "University of Arkansas, Fayetteville" with 17 trials, followed by "BrainScope Company, Inc." with 6 trials sponsored, "Columbia University" with 1 trials sponsored, "ImPACT Applications, Inc." with 1 trials sponsored and "Jazz Pharmaceuticals" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University of Arkansas" #1 collaborator was "United States Department of Defense" with 4 trials as a collaborator, "University of Arkansas" with 3 trials as a collaborator, "Danone Research" with 1 trials as a collaborator, "National Cancer Institute (NCI)" with 1 trials as a collaborator and "National Institute for Biomedical Imaging and Bioengineering (NIBIB)" with 1 trials as a collaborator. Other collaborators include 4 different institutions and companies that were collaborators in the rest 14 trials.

According to Clinical.Site data, the most researched conditions in "University of Arkansas" are "Concussion, Brain" (6 trials), "Concussion, Intermediate" (6 trials), "Concussion, Mild" (6 trials), "Brain Injuries, Traumatic" (5 trials) and "Concussion, Severe" (5 trials). Many other conditions were trialed in "University of Arkansas" in a lesser frequency.

Most popular intervention types in "University of Arkansas" are "Dietary Supplement" (10 trials), "Device" (8 trials), "Other" (7 trials), "Behavioral" (4 trials) and "Diagnostic Test" (1 trials). Other intervention types were less common.

The name of intervention was led by "BrainScope Ahead 200iD" (3 trials), "Advanced MRI Neuroimaging" (2 trials), "BrainScope Ahead 300iP" (2 trials), "Animal protein" (1 trials) and "BrainScope Ahead 300iP-O" (1 trials). Other intervention names were less common.

The vast majority of trials in "University of Arkansas" are 21 trials for "All" genders, 4 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "University of Arkansas". undefined are not yet recruiting, 5 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 18 completed trials in University of Arkansas, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in University of Arkansas, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 18 trials that are defined as “Not Applicable".